3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow vaniprevir: new trials by email Literature Review of vaniprevir trials Research Report on vaniprevir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045) Vaniprevir, peg-IFN, ribavirin - Hepatitis C, Chronic | Phase 3 | Completed | Merck Sharp & Dohme LLC | 42 | 2011-09-02 | 2018-10-18 |
| Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044) vaniprevir, peg-IFN, ribavirin - Hepatitis C, Chronic | Phase 3 | Completed | Merck Sharp & Dohme LLC | 51 | 2011-08-29 | 2018-10-18 |
| Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043) vaniprevir, Placebo to vaniprevir, Peg-IFN - Hepatitis C, Chronic | Phase 3 | Completed | Merck Sharp & Dohme LLC | 294 | 2011-06-27 | 2018-10-18 |